{"ok":true,"trend":{"id":18193,"platform":"mastodon","region":"global","key":"kobayashi pharmaceutical, the firm that was at the center of a supplement contamination scandal involving suspected deat","title":"Kobayashi Pharmaceutical, the firm that was at the center of a supplement contamination scandal involving suspected deat","url":"https://mastodon.social/@thejapantimes/117328277742677349","first_seen":"2026-09-26T19:48:50.557681Z","last_seen":"2026-09-26T22:32:37.145206Z","last_rank":1,"peak_rank":1,"last_volume":4,"peak_volume":4,"seen_count":3,"score":95.38,"category_hint":"markets","section":"business","category":"markets","summary":"Kobayashi Pharmaceutical, the Japanese company at the center of a supplement contamination scandal linked to suspected deaths, is reportedly considering a buyout offer valued at more than ¥500 billion. The news comes as the firm continues to face fallout over its beni-koji (red yeast rice) supplements. Reports of a potential acquisition are drawing attention to the company's future ownership and accountability over the scandal.","why":"Reports of a multibillion-yen buyout for a company notorious for a deadly supplement scandal are newly circulating.","tone":"neutral","entities":["Kobayashi Pharmaceutical"],"summarized_at":"2026-09-26T19:53:05.090757Z","meta":{"tag":"stocks","via":"scan","kind":"status","lang":"en","generic":0.03,"instance":"mastodon.social","tag_uses":13},"nw":0.71,"promo":0.02,"kind":"news_event","importance":1.83,"hidden":false,"hide_reason":null,"judged_at":"2026-09-26T19:48:51.143613Z","title_en":"Kobayashi Pharmaceutical weighs takeover offer above ¥500 billion","section_name":"Business","category_name":"Markets","timeline":[{"captured_at":"2026-09-26T19:48:50.557681Z","rank":1,"volume":4},{"captured_at":"2026-09-26T21:10:36.991590Z","rank":1,"volume":4},{"captured_at":"2026-09-26T22:32:37.145206Z","rank":1,"volume":4}],"posts":[{"platform":"mastodon","url":"https://mastodon.social/@thejapantimes/117328277742677349","author":"thejapantimes","title":null,"snippet":"Kobayashi Pharmaceutical, the firm that was at the center of a supplement contamination scandal involving suspected deaths, is said to be considering a potential buyout offer of more than ¥500 billion. https://www. japantimes.co.jp/business/2026…","posted_at":"2026-09-24T22:04:01.144000Z","likes":4}],"elsewhere":[],"window":"7d"}}